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Abstract
Background
The most important factor influencing maternal vaccination uptake is healthcare profes-
sional (HCP) recommendation. However, where data are available, one-third of pregnant
women remain unvaccinated despite receiving a recommendation. Therefore, it is essential
to understand the significance of other factors and distinguish between vaccines adminis-
tered routinely and during outbreaks. This is the first systematic review and meta-analysis
(PROSPERO: CRD 42019118299) to examine the strength of the relationships between
identified factors and maternal vaccination uptake.
Methods
We searched MEDLINE, Embase Classic & Embase, PsycINFO, CINAHL Plus, Web of
Science, IBSS, LILACS, AfricaWideInfo, IMEMR, and Global Health databases for studies
reporting factors that influence maternal vaccination. We used random-effects models to
calculate pooled odds ratios (OR) of being vaccinated by vaccine type.
Findings
We screened 17,236 articles and identified 120 studies from 30 countries for inclusion. Of
these, 49 studies were eligible for meta-analysis. The odds of receiving a pertussis or influ-
enza vaccination were ten to twelve-times higher among pregnant women who received a
recommendation from HCPs. During the 2009 influenza pandemic an HCP recommenda-
tion increased the odds of antenatal H1N1 vaccine uptake six times (OR 6.76, 95% CI 3.12–
14.64, I2 = 92.00%). Believing there was potential for vaccine-induced harm had a negative
influence on seasonal (OR 0.22, 95% CI 0.11–0.44 I2 = 84.00%) and pandemic influenza
vaccine uptake (OR 0.16, 95% CI 0.09–0.29, I2 = 89.48%), reducing the odds of being
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vaccinated five-fold. Combined with our qualitative analysis the relationship between the
belief in substantial disease risk and maternal seasonal and pandemic influenza vaccination
uptake was limited.
Conclusions
The effect of an HCP recommendation during an outbreak, whilst still powerful, may be
muted by other factors. This requires further research, particularly when vaccines are novel.
Public health campaigns which centre on the protectiveness and safety of a maternal vac-
cine rather than disease threat alone may prove beneficial.
Introduction
Maternal vaccination aims to reduce maternal and neonatal morbidity and mortality caused
by infection [1]. The World Health Organisation (WHO) recommends the inactivated influ-
enza, tetanus-toxoid-containing vaccine (TTCV), and combined tetanus, diphtheria, and acel-
lular pertussis (Tdap) vaccines for pregnant women in settings where the disease burden is
known [2]. Historically, maternal tetanus vaccination was limited to areas of significant trans-
mission. In areas where there is ongoing maternal to neonatal transmission of tetanus, two
doses of TTCV (preferably Tetanus-diphtheria) are recommended in pregnancy in addition to
Tdap or DTaP (for pertussis) and seasonal influenza vaccines.[2] Pertussis vaccination was
limited to childhood, however the resurgence of pertussis during outbreaks that dispropor-
tionately affected younger infants led to national policy changes between 2011 and 2015 in
countries such as the United Kingdom and the United States, that introduced routine maternal
pertussis vaccination.[2,3] Similarly, the widespread influenza immunisation programs during
the 2009 H1N1 pandemic resulted in public health bodies particularly in Europe, the United
States and Australia introducing guidance to implement recommendations for routine antena-
tal seasonal influenza vaccination during the subsequent decade. The United States Healthy
People 2020 campaign sets a target to achieve influenza vaccination coverage of 80% among
pregnant women [4]. Suboptimal maternal vaccination coverage (estimated between 0–70%)
of seasonal influenza and pertussis vaccines globally represents a missed opportunity to
improve maternal and neonatal health [3–6]. Understanding the features that contribute
to reduced uptake of vaccines used in outbreaks is also of particular importance given the
increased morbidity and mortality seen with infections contracted during the vulnerable
period of pregnancy [7].
In the last decade, the World Health Organisation has declared multiple Public Health
Emergencies of International Concern for diseases including outbreaks of the Ebola virus
(West Africa, North Kivu), Zika virus, and the novel Coronavirus (Wuhan) (COVID-19) [8,
9]. Ebola and Zika are known to cause significant morbidity and mortality if contracted during
pregnancy, whereas the effect of the COVID-19 is unknown [10]. A vaccination strategy has
been developed for Ebola, and vaccine research is underway for Zika virus and COVID-19.
The concern of disease risk may be amplified during an outbreak, but concerns about using a
novel vaccine may also be enhanced. It is important to identify factors that appear to affect
antenatal vaccine uptake during routine use (pertussis and influenza) versus vaccinations rec-
ommended during an outbreak setting (H1N1 influenza) to help prepare for future outbreaks.
Understanding the influence of personal beliefs and experiences on maternal vaccination
uptake is key to designing, testing and deploying interventions that are tailored to improve
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vaccine acceptance and coverage in routine and outbreak settings. Researchers have investi-
gated the underlying reasons for low coverage using surveys, focus group discussions, and in-
depth interviews to explore the perceptions and experiences of pregnant women. Previous
reviews have established a narrative of evidence that suggests a broad range of factors (vaccine
cost, accessibility, maternal knowledge, social influences, context, healthcare professional
(HCP) recommendation and the perception of risks and benefits) all contribute to vaccine
uptake. Consensus within the field and across four prior literature reviews indicate that receiv-
ing a recommendation from an HCP for vaccination is the most important factor in maternal
decision-making, irrespective of geographic or social context [11–15]. In general, there is lim-
ited data on maternal vaccination uptake and records of HCP recommendations at a national
level. However, for the United States of America (USA), which monitors antenatal seasonal
influenza and pertussis vaccination coverage, data suggest approximately one-third of women
who receive an HCP recommendation for the vaccine will choose to remain unvaccinated [5].
In 2018, the Centers for Disease Control and Prevention (CDC) found that 79.3% of pregnant
participants received a recommendation or an offer for Tdap vaccine, but 45.6% of them chose
to remain unvaccinated [5]. For seasonal influenza, fewer women chose to vaccinate when rec-
ommended to do so; 81.1% received a recommendation or an offer yet 50.9% of pregnant
women surveyed remained unvaccinated [5]. Understanding why women remain unvacci-
nated despite an HCP recommendation is key. We also sought to discriminate factors that
influence specific vaccines since seasonal influenza vaccination coverage is lower than other
routine vaccines (Tdap, tetanus) during pregnancy.
Prior literature and systematic reviews tend to characterize the factors influencing maternal
vaccination decisions as either barriers or facilitators [11–15]. We sought to quantify the asso-
ciation between beliefs, attitudes and prior behaviours that influence maternal vaccination
uptake. We selected the H1N1 Influenza vaccine, deployed globally and recommended to
pregnant women during the pandemic of 2009, to be included alongside our analysis of other
WHO routinely recommended vaccines, the pertussis and seasonal influenza vaccine. Thus,
we performed a systematic review and meta-analysis of qualitative and quantitative literature
to provide comprehensive evidence on the magnitude of effect that factors influence maternal
vaccination decisions globally with the aim to inform policy makers, public health strategists
and researchers involved in designing vaccine interventions to increase uptake.
Materials and methods
Search strategy and selection criteria
We conducted a systematic review of literature, unrestricted by language or location, to iden-
tify qualitative and quantitative studies that reported on the cognitive, psychological, and social
factors associated with maternal vaccination among pregnant and recently pregnant women
(within two years of birth). We searched MEDLINE, Embase Classic and Embase, PsycINFO,
CINAHL Plus, Web of Science, IBSS, LILACS, AfricaWideInfo, IMEMR, and Global Health
for studies published by 22 November 2018 (Appendix p3-10 in S2 File). Additional studies
were identified by screening reference lists (EK, SD) of previous reviews and through sugges-
tions by experts in the field.
Titles and abstracts were independently screened and agreed upon (EK, SD) for potential
eligibility. A final arbiter (PP) resolved any conflicts of agreement on inclusion. We excluded
pre-clinical research, behavioural intervention studies, and any research that exclusively exam-
ined experimental vaccines in pregnancy or sociodemographic variables (Appendix p11-15 in
S2 File).
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To be included in the meta-analysis, studies had to report an estimated odds ratio (OR (or
could be calculated from raw data)) for the association between a specific factor and vaccina-
tion status (excluding intention to be vaccinated). Research groups from studies in which the
data were unclear or had not been reported were contacted for clarification (Appendix p51 in
S2 File).
Data analysis
The data from included studies were extracted (EK, SD) and input into Microsoft Excel
(Microsoft Corporation, Redmond, WA, USA) and a coding template was developed by
authors to categorise factors influencing maternal vaccination uptake (Expanded Methodology
Appendix p18-19 in S2 File details why established frameworks were not used). Coding into
broad themes (e.g. accessibility and convenience) using grounded theory was completed inde-
pendently (EK, SD) with NVivo 12 (QSR International, Melbourne, Australia) (Inter-rater reli-
ability kappa score 0.76).
The quantitative studies were independently assessed (EK, MRF) for inclusion in the meta-
analysis based on first cycle broad codes to capture data that could be synthesized (Appendix
p38-40 in S2 File). Qualitative data underwent a second round of coding to identify specific
patterns within the broad themes (Inter-rater reliability kappa score 0.88). A third round of
coding (subdividing the first cycle codes) was conducted to ensure that only data that was
directly comparable were included in each meta-analysis (Appendix p41 in S2 File). Twenty-
three narrow definitions were agreed upon by two authors (EK, MRF) to ensure consistency of
the data included (Appendix p42-43 in S2 File). These definitions were used to pool studies for
specific vaccines (seasonal influenza, pandemic influenza, and pertussis) generating 31 separate
meta-analyses (EK, MRF). Any discrepancies in data extraction were resolved by both authors.
Quality appraisal was performed (EK, SD) using checklists for cross-sectional, cohort, and
qualitative research studies from the Joanna Briggs Institute quality assessment tools (Appen-
dix p21-32 in S2 File).[16] Studies were ranked based on a framework developed by authors
with an attributed quality score. Where authors disagreed on final point allocation, the arbiter
(PP) intervened to resolve the disagreement. Quality analysis was not used to define inclusion
or exclusion. However, pre-specified sensitivity analyses were performed investigating the
robustness of results to the inclusion of only high-quality studies (Joanna Briggs Institute
scores>10) (Appendix: p90, p92 in S2 File). We wished to conduct a sensitivity analysis assess-
ing the robustness of results by Gross Domestic Product of countries included to assess the
influence of geographic context.
When two or more studies reported ORs for a specific factor, random-effects models were
used to calculate a summary OR [17] with heterogeneity assessed with I2. Funnel plots were
used to examine the potential for publication bias. Specific factors reported by only one study
are summarised in the appendix (Appendix p93 in S2 File). A secondary analysis was per-
formed to assess factors associated with intention to be vaccinated during pregnancy. All
meta-analyses were conducted in Stata 15 (StataCorp, College Station, TX, USA) [18, 19].
The PRISMA checklist (Preferred Reporting Items for Systematic Review and Meta-Analy-
sis checklist) (Appendix p16-17 in S2 File) [20] was used and the study was registered with
PROSPERO (International Prospective Register of Systematic Reviews) (CRD42019118299).
An expanded methodology can be found in the appendix (Appendix p19-21 in S2 File).
Results
Of 17,236 articles screened, 120 were eligible for analysis (Fig 1). Table 1 summarises study
characteristics, representing data from 73,251 pregnant or recently pregnant women and 30
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Fig 1. PRISMA diagram of included and excluded studies. Adapted from Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group
(2009). Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/
journal.pmed1000097.
https://doi.org/10.1371/journal.pone.0234827.g001
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countries (Appendix p33-37 in S2 File). The majority of studies were quantitative only (n = 99),
then qualitative only (n = 18) with three studies using mixed methods (Table 1). Studies were
predominantly from the USA (39 studies), Australia (22), and Canada (9). Seasonal influenza
vaccine was the most commonly investigated vaccine, either independently or as part of a study
of factors influencing the uptake of multiple vaccines (63% of studies n = 75), followed by vac-
cines against pertussis (27% n = 32), pandemic influenza (24% n = 29), tetanus (8% n = 9), and
antenatal vaccines generally (2% n = 2).
We identified eight categories of factors that influence maternal vaccination across both
qualitative and quantitative studies: accessibility and convenience (55 studies), personal values
and lifestyle (43), awareness of information regarding the specific vaccine or disease of focus
(90), social influences on vaccine use (109), emotions related to vaccination (85), perceptions
of vaccine risk (110), perceptions of vaccine benefit (93), and personal vaccination history
(80). From these eight categories, five could be synthesised quantitatively (Appendix p40-41 in
S2 File). Results from all meta-analyses are presented in Fig 2. No data for tetanus vaccination
were suitable for meta-analysis. A list of the most common barriers or facilitators cited in stud-
ies excluded from meta-analysis is available in the appendix (Appendix p52-53 in S2 File).
From the 21 qualitative studies, we identified 30 sub-categories of factors that appear to influ-
ence maternal vaccination decision-making (Table 2).
Quantitative studies
For our primary analysis we conducted 33 meta-analyses which assessed the relationship
between a specific belief or behaviour and maternal vaccination status (338–14,099 participants
Fig 2. Factors associated with maternal vaccine uptake—A summary forest plot. Abbreviations. HCPR—healthcare professional
recommendation, General—generally, P. Flu—pandemic influenza vaccine, SE—side effects, S. Flu—seasonal influenza vaccine.
https://doi.org/10.1371/journal.pone.0234827.g002
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(average 2,955) included in each meta-analysis)) (Appendix p55-89 in S2 File for individual
meta-analyses and summary table) (Fig 2). For our secondary analysis we conducted 15 meta-
analyses assessing the relationship between a specific belief or behaviour and maternal vaccina-
tion intentions, rather than prior behaviour (531–2,215 participants (average 1,344) included
in each meta-analysis)) (Appendix p91 in S2 File). The majority of studies with quantitative
results for the pertussis vaccine had investigated intention to be vaccinated rather than actual
vaccination status. Pregnant women who had received an HCP recommendation had 12-times
higher odds of accepting seasonal influenza vaccination (OR 12.02, 95% CI 6.80–21.23, 21
studies, 14,099 women) [21–41] and 10-times greater odds of accepting pertussis vaccine
(OR 10.33, 95% CI 5.49–19.43, 2 studies, 637 women) [27, 29] compared to those who had
not received recommendations. For pandemic vaccine the recommendation increased the
odds of antenatal H1N1 vaccine uptake by six times (OR 6.76, 95% CI 3.12–14.64, 5 studies,
6898women) [42–46]. The odds of pregnant women receiving season influenza vaccination
were five-times higher if they had general information about the vaccine (OR 5.68, 95% CI
1.53–21.13,4 studies, 1193 women) [22, 27, 31, 47]. Similarly, the odds of being vaccinated
were three-times higher (OR 3.68, 95% CI 2.12–6.38, 4 studies, 3583 women) [37, 40, 48, 49]
among pregnant women who knew there was a national vaccination policy in place versus
women who were unaware.
Prior vaccination history was influential in subsequent maternal vaccination decisions. The
odds of being vaccinated against seasonal influenza were three-times greater (OR 3.78, 95% CI
2.49–5.73, 10 studies, 5,768 women) [23, 24, 27, 38, 40, 41, 48–51] and five-times greater for
vaccination against pandemic influenza (OR 5.49, 95% CI 2.44–12.37, 3 studies, 2,387 women)
[42, 45, 46, 52] if pregnant women had received vaccines as adults outside of pregnancy. Preg-
nant women who received a seasonal influenza vaccination during a prior pregnancy had
nine-times higher odds of accepting a pandemic influenza vaccine in their current pregnancy
than those who did not vaccinate in a prior pregnancy (OR 9.12, 95% CI 1.99–41.76, 2 studies,
442 women) [43, 53]. There was no evidence to suggest an association between prior maternal
vaccination and season influenza vaccinations (OR 1.51, 95% CI 0.71–3.24, 3 studies, 2,339
women) [21, 22, 47].
The odds of accepting the pandemic influenza vaccine were six-times lower when women
perceived it as unsafe in pregnancy (OR 0.16, 95% CI 0.09–0.29, 6 studies, 5,525 women) [42,
44–46, 54, 55]. Similarly, the odds of accepting the seasonal influenza vaccine were 86% lower
when women believed receiving the vaccine during pregnancy was unsafe (OR 0.22, 95% CI
0.11–0.44, 7 studies, 3,200 women) [24, 25, 31, 37, 39, 48, 56]. Additionally, perceiving that the
pandemic influenza vaccine caused harms such as birth defects (OR 0.19, 95% CI 0.09–0.40, 2
studies, 629 women) [46, 49] or miscarriage (OR 0.19, 95% CI 0.10–0.38, 2 studies, 1,574
women) [42, 46] were both associated with a five-times lower odds of vaccination. |Having
concerns about pandemic influenza vaccine side-effects in general (OR 0.44, 95% CI 0.23–
0.81, 2 studies, 760 women) [46, 53] was associated with two-times lower odds of vaccination;
having knowledge of specific pandemic influenza vaccine side-effects (defined as a awareness
of a known adverse reaction as outlined by the drug company label insert, e.g. fever.) (OR 0.27,
95% CI 0.21–0.34, 2 studies, 1,325 women) [42, 54] was associated with three-times lower odds
of vaccination.
In contrast, the odds of being vaccinated were eight-times higher when pregnant women
believed that the pandemic influenza vaccine benefits the mother (OR 8.44, 95% CI 2.90–
24.61, 2 studies, 338 women) [49, 54]. The odds of accepting the seasonal influenza vaccine
were seven-times greater when pregnant women perceived the vaccine as generally effective
(OR 7.22, 95% CI 3.49–14.93, 6 studies, 5,814 women) [21, 24, 37, 39, 40, 57], three-times
greater when they believed the vaccine benefits the mother (OR 3.47, 95% CI 2.19–5.51, 6
PLOS ONE Factors that influence vaccination decision-making among pregnant women
PLOS ONE | https://doi.org/10.1371/journal.pone.0234827 July 9, 2020 13 / 28
studies, 3,144 women) [23, 25, 31, 37, 49, 56], and almost two-times greater when they believed
the vaccine benefits their baby (OR 1.74, 95% CI 1.18–2.57, 7 studies, 2546 women) [25, 31, 37,
38, 41, 49, 56].
There was insufficient evidence on the influence of perceived susceptibility to pandemic
influenza during pregnancy on pandemic influenza vaccination uptake (OR 1.11, 95% CI
0.56–2.19, 5 studies, 4,044 women) [45, 49, 53–55]. However, pregnant women who felt they
were susceptible to seasonal influenza had almost two-times higher odds of vaccination than
those who did not feel susceptible to contracting seasonal influenza (OR 1.76, 95% CI 1.26–
2.47, 5 studies, 4,763 women) [24–26, 40, 49]. There was inconclusive evidence to support a
similar association between perceptions of the severity of pandemic (OR 2.04, 95% CI 0.98–
4.26, 4 studies, 5,948 women) [42, 44, 53, 54] or seasonal influenza (OR 1.56, 95% CI 0.88–
2.76, 4 studies, 2,671 women) [24–26, 39] with vaccination status. However, pregnant
women who believed seasonal influenza could be harmful to their pregnancy or baby had
four-times greater odds of being vaccinated than those who did not believe seasonal influ-
enza could affect their pregnancy or baby (OR 3.70, 95% CI 1.37–9.94, 3 studies, 1,748
women) [23, 31, 48].
When the number of studies included in the meta-analysis exceeded seven, funnel plots
were used to assess the potential for publication bias (Appendix p54 in S2 File). Although
based on a small number of studies, there was incomplete agreement between the primary and
secondary analyses (intention to be vaccinated meta-analysis results are provided in Appendix
p91-92 in S2 File). Sensitivity analyses including studies with Joanna Briggs Institute scores
>10 were conducted for both vaccination status and intention to be vaccinated outcomes
(Appendix: p90, p92 in S2 File). Whilst results were generally consistent, differences were diffi-
cult to interpret due to the low number of higher-quality studies.
Qualitative studies
All qualitative studies reported on the perceived effect of HCP influence on decision-making,
and to a lesser extent the influence of other social networks or the Internet. Often an offer (or
lack of an offer) of vaccination during an antenatal visit was a key factor in final behaviour
[58–60]. Participants also expressed willingness to receive information from HCPs, but were
disappointed with a perceived overuse of leaflets to convey information in lieu of direct con-
versation with an HCP [58, 61, 62]. Other studies reported that some pregnant women sought
vaccination information through media or the Internet, but these avenues were not regarded
as the most reliable for accurate information [62–66].
Almost all qualitative studies indicated that being aware of maternal vaccination and/or the
respective disease, regardless of information source, was key to receiving the vaccine but rarely
sufficient (17 studies) [56, 58–73]. Furthermore, 16 qualitative studies highlighted an informa-
tion gap specific to knowledge of vaccines during pregnancy [56, 58–71, 73], reflecting a gen-
eral lack of awareness among pregnant women of maternal vaccine recommendations and
benefits.
Qualitative studies identified a number of additional health concerns about antenatal vac-
cines such as narcolepsy [58], infertility [70], autism [65], and unknown risks [61, 62, 68,
74–76] in addition to concerns of birth defects [63, 65, 68] and miscarriage [62–64, 68, 70]
(Table 2). Specific side-effect concerns included vomiting, fever, body aches, soreness, fainting,
seizures, illness, and unknown short and long-term side-effects [56, 58, 61, 65, 67, 71, 73–77].
Whilst the benefits of vaccines were mentioned in 16 qualitative studies, 11 of these studies
reported that there was also doubt and uncertainty around the usefulness or the efficacy of vac-
cines in pregnancy [59, 61, 62, 64–66, 68, 70, 73, 75, 76].
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In eight of the 17 qualitative studies that examined perceptions of disease severity, partici-
pants were unaware of the additional risks of influenza to pregnant women [56,62, 64, 66–68,
74, 75]. Qualitative studies also highlighted differences in participants’ perceptions of severity
for different diseases. For example, H1N1 or pandemic influenza was perceived as more severe
than seasonal influenza [68, 74]. Additionally, pertussis was correctly seen primarily to present
danger to infants, whereas influenza was viewed as a significant risk to the pregnant woman
[60]. Whilst the disease risk was used as a contributing factor to final decision other factors
were weighed against it.
Whilst factors such as convenience, personal values, and emotions related to vaccinations
during pregnancy were not captured in our meta-analyses, they were highlighted in qualitative
analyses. Several studies reported on vaccine availability [56, 59–62, 65, 70, 77], access [58, 73,
77], and competing priorities in pregnancy [56, 58, 60, 61, 73]. In some studies, participants
may have accepted vaccines generally, but not during pregnancy [56, 66, 76]. Community
rumours and cultural values also influenced views on vaccination among pregnant women
[69, 70, 73, 75]. Additionally, several studies reported preferences for natural immunity or a
healthy lifestyle during pregnancy as reasons to decline vaccinations [61, 62, 66, 68, 76]. Mater-
nal vaccination decision-making was also associated with several emotions and sentiments
including fear (13 studies) [61, 62, 64, 67–73, 75–77], worry or anxiety (8 studies) [56, 58, 61,
63, 67, 70, 72, 77], responsibility for pregnancy outcomes and culpability if something goes
wrong (5 studies) [61, 68, 71, 73, 76], and uncertainty about risks associated with vaccination
decisions (3 studies) [63, 75, 76]. Pregnant women feared the unknown [68, 70–72] the disease
(particularly for pandemic influenza) [62, 68, 70, 73], vaccine harm or side-effects [61, 64, 67,
69, 70, 75, 76], vaccine safety [64, 73], and pain [52, 61,77]. One study reported that vaccinated
and unvaccinated pregnant women expressed similar fears, but unvaccinated women often
described their fears in more detail [70]. The fear of perceived vaccine harms (including the
ideas of unknown risks for novel vaccines) were used to explain the rejection of maternal vac-
cination despite a connected fear of the disease it was aimed to protect against [59, 64–68, 70–
73, 75].
Discussion
Despite the challenges of synthesizing an extensive and varied body of research, we have been
able to quantify the relative effect size for a large number of specific beliefs and behaviours
around maternal vaccination uptake. Prior attempts to weight factors influencing maternal
vaccination uptake have largely been confined to ranking the most commonly cited barriers or
facilitators within studies, listing the latter as predictors. This approach is likely to conflate sev-
eral individual factors which are important to designing better interventions aimed at increas-
ing maternal vaccination acceptance and uptake.
Our major finding is that vaccine-specific factors and previous vaccination behaviour have a
strong influence on antenatal vaccine uptake. Disease-related perceptions have a modest effect
on final vaccination uptake. Beliefs that vaccine would benefit the mother or cause no harm to
the pregnancy were associated with four-to-nine-times greater odds of vaccination-acceptance
during pregnancy. Prior systematic reviews were unable to characterise the nature or strength
of effect of vaccine safety concerns on maternal vaccination decisions. Lutz et al. described
that 2.9 to 77% of pregnant women had safety concerns for their foetuses [13]. Wilson et al.
reported that safety concerns were the most frequently cited barriers (64 of 155 studies) but
the relationship of this concern to final vaccination uptake was not defined. The underlying
vaccination status of pregnant women was unreported in this prior study, limiting the inter-
pretation of this finding [11]. In our study, beliefs that vaccine could cause birth defects or
PLOS ONE Factors that influence vaccination decision-making among pregnant women
PLOS ONE | https://doi.org/10.1371/journal.pone.0234827 July 9, 2020 15 / 28
general harm in pregnancy served as strong deterrents to both seasonal and pandemic influ-
enza vaccination (seasonal OR 0.22, 95% CI 0.11–0.44; pandemic OR 0.11, 95% CI 0.06–0.22).
Similarly, perceptions of vaccine utility had a strong positive influence on uptake. For the sea-
sonal influenza vaccine, perceiving the vaccine as beneficial in general was an important factor
associated with pregnant women’s vaccination status (OR 7.22, 95% CI 3.49–14.93). For pan-
demic influenza vaccination, despite the wide confidence intervals, our data suggest that per-
ceptions that vaccine can protect pregnant women (OR 8.44 95% CI 2.90–24.61) is strongly
associated with vaccine uptake.
Our study did not find clear evidence that a belief of susceptibility to pandemic or seasonal
influenza was associated with increased maternal pandemic influenza vaccination (OR 1.11,
95% CI 0.56–2.19) or seasonal influenza (OR 1.76, 95% CI 1.26–2.47) vaccine uptake. There
was some evidence to support an association between perceptions of the severity of pandemic
influenza and pregnant women’s vaccination status (OR 2.04, 95% CI 0.98–4.26) with the
belief that pandemic influenza can result in hospitalisation increasing vaccine uptake three-
fold (OR 2.91, 95% CI 2.02–4.18). We would recommend additional studies to explore the role
of disease severity and susceptibility in greater detail to clarify their importance when other
factors are present. For seasonal influenza, the data is inconclusive since women who believed
that the disease could be harmful to their pregnancy or baby had four-times greater odds of
being vaccinated than those who did not (OR 3.70, 95% CI 1.37–9.94) yet there was no evi-
dence to suggest belief in the risk of the disease generally (OR 1.56, 95% CI 0.88–2.76) or its
ability to result in hospitalisation (OR 0.57, 95% CI 0.22–1.45) were related to vaccine uptake.
This was mirrored by our qualitative research which indicated that the influence of a belief in
the severity and susceptibility to a disease does not in isolation determine vaccination decision
[56, 58, 59, 63–71, 73–76]. This has important implications for public health communication
strategies around maternal vaccination since campaigns, particularly during an epidemic or
influenza outbreak, have centred around disease threat. Based on our findings we caution any
communication approach which highlights only the threat of disease when publicising vacci-
nation. We suggest this requires further review of the messaging strategies comparing those
with and without explicit details of vaccine safety to the public and/or a discussion of disease
threat with attention to language which might inadvertently promote fear [78]. The global
communication strategies during the H1N1 2009 pandemic have been widely criticised as
lacking an evidence-base and not appropriately targeting specific vulnerable groups [79]. We
suggest that future research investigates disease-focused communication strategies versus vac-
cine-centred communication when discussing maternal vaccination to help prepare for future
pandemics. Our study was conducted prior to the North Kivu Ebola vaccine deployment
among pregnant women in 2019. This study precedes vaccine candidate deployment for
SARS-CoV-2 with immediate implications for future studies analysing potential acceptance of
a maternal vaccine and the associated communication strategy. This is an important area of
investigation to analyse the factors that influence maternal uptake when the vaccine is still in
an experimental part of outbreak control. Whilst the analysis of purely experimental vaccines
was outside the remit of this work, we suggest further investigation into assessing the impor-
tance of factors identified in this review (including fear-conflict, anxiety and specific safety
concerns) and their influence on uptake of vaccine during its developmental phase at the time
of an outbreak.
Our findings also have potential implications for future study design. Many studies included
in this systematic review and meta-analysis were designed using the framework of the Health
Belief Model [24–26, 28, 39, 40, 53, 54, 60, 62–64, 69, 73, 80–88]. In brief, the Health Belief
Model describes final vaccination acceptance or rejection based on the interacting beliefs of
seriousness and susceptibility to the target disease of the vaccine, benefits of the intervention,
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and barriers in order to predict health behaviour. Our study suggests that the model should be
adapted to highlight the importance of the latter two categories in maternal vaccination behav-
iour predictions.
Consistent with the extensive body of evidence on this topic, an HCP recommendation for
routine vaccinations (seasonal influenza and pertussis vaccination) was a very strong factor
influencing maternal vaccine acceptance that is associated with ten-times greater odds of
being vaccinated over those who did not receive an HCP recommendation (pertussis OR
10.33, 95% CI 5.49–19.43; seasonal influenza OR 12.02, 95% CI 6.80–21.44).
Although based on a small number of studies, our meta-analysis suggests that the influence
of an HCP recommendation for pandemic influenza vaccination moderately-to-strongly influ-
ences uptake. Pandemic vaccine uptake was closely related to prior vaccination behaviour.
Vaccination (with a different vaccine) during a prior pregnancy (OR 9.12 95% CI 1.99–41.76)
had a strong influence on pandemic vaccine uptake. Interestingly, this did not appear as evi-
dent for receiving an antenatal seasonal influenza vaccine in a subsequent pregnancy (OR
1.51, 95% CI 0.71–3.24). This suggests a possibility that decision-making for seasonal influenza
vaccines made in second and third pregnancies may not be consistent with the decisions in
the first pregnancy [89]. Whilst studies have often included a sample of second- or third-time
mothers, there is less extensive evidence of temporal changes in decision-making factors for
maternal vaccines.
Whilst a general awareness about maternal vaccination did not increase the odds greatly
of pandemic vaccine uptake, it appeared key for routine antenatal vaccines. Policy aware-
ness was strongly associated with seasonal influenza vaccination uptake. National recom-
mendations from the authoritative health bodies appear to carry weight in maternal
vaccination decision-making at a population level [90]. This is important for the rollout
of new maternal vaccines, as vaccinations not endorsed by national policy may be less
accepted. Publicising such policies could improve trust in maternal vaccination pro-
grammes and facilitate improved uptake.
Qualitative findings from focus group discussions and in-depth interviews were generally
consistent with the quantitative results: an unambiguous recommendation from an HCP to
vaccinate against seasonal influenza or pertussis is key to pregnant women being vaccinated
[58–66, 68, 72, 73, 76, 77]. It is difficult to draw conclusions about which specific HCP (e.g.
obstetrician, general practitioner, and midwife) or service provider (e.g. community or hospi-
tal-based practitioners) is the most influential. Similar to the quantitative literature, qualitative
studies have shown that a recommendation by an HCP was not always sufficient [26, 34, 36,
41, 45, 46, 62, 63, 67]. Reasons for refusal despite HCP recommendation from the qualitative
analysis provide insights into the effects of fear, mistrust, and a feeling of accountability [61,
63, 67, 73, 75]. In the face of uncertainty about a vaccine, a guarded state prevails despite con-
cern for disease risk [61, 68, 71, 73, 76]. This was most notably captured by Meharry et al. as,
“. . .fear if I do (vaccinate), fear if I don’t (vaccinate), and do nothing when I fear both” [73].
This analysis, combined with the finding of a very strong relationship between the belief of
vaccine harm and reduced uptake indicates that the perceived risk of self-intervening (i.e. tak-
ing a vaccine) can be very powerful. This can overshadow the belief in environmental risk (e.g.
contracting a severe disease). This suggests that mothers feel accountable for a perceived risk
when choosing to vaccinate during pregnancy, which can result in inaction if the disease is
also feared. Whilst it is essential that pregnant women are informed about the risks of the dis-
ease in order to be appropriately consented, the manner in which this is communicated should
be evaluated. It appears that, in some cases, fear may be counter-productive. This has been
seen in childhood vaccines: if parents already fear the vaccine, making them fear the disease
leads to decision conflict, and hesitancy [91].
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By including qualitative analysis, we were also able to unravel specific, participant-driven
concerns that ranged from possible adverse events such as narcolepsy, infertility, and autism
spectrum disorder as well as pregnancy-related concerns such as suspected risks of miscar-
riage, preterm birth, and birth defects. Since the non-pregnancy related health concerns occur
rarely in the general population or require long-term follow up over decades, post-marketing
surveillance studies are used to measure if there are any vaccine-related effects [92]. However,
data on these specific concerns during pregnancy are often unavailable to general practitioners
or midwives during counselling. We recommend that HCPs are given ready access to clear
and concise language on the safety of vaccines during pregnancy. The CDC has launched
an extensive response to the relationship between antenatal vaccines and Guillain Barre syn-
drome, autism, febrile seizures and sudden infant death syndrome (SIDS) [93–103]. However,
discussions on narcolepsy are made in reference to childhood rather than prenatal vaccination.
Additionally, there is limited availability of summarized reports for the public or general prac-
titioners that synthesize the abundance of safety evidence on miscarriage, infertility, and birth
defects. Health bodies should make this widely generated safety evidence more accessible to
the public and to HCPs to facilitate uptake where concerns in practice arise [103, 104].
It is reassuring that our meta-analysis reinforces some of the existing evidence surrounding
factors that influence maternal vaccine uptake. Attempting to quantify an effect size adds a
useful summary measure. However, our study has a number of limitations that potentially
impact inferences drawn from these data. The evidence-base exploring the factors determining
antenatal vaccination decisions is extensive but of mixed quality, and synthesis of the results
was complicated by the contextual and methodological heterogeneity between studies. A par-
ticular challenge was synthesizing questionnaire data which used variable phrasings and posed
different assortments of questions limiting the volume of data that could be synthesised.
Ninety-seven percent of quantitative studies pooled employed a cross-sectional design. We
acknowledge that in some settings, where data are obtained using variable questionnaires,
examining a different number of factors, pooling information may obtain inconsistent results.
However, in practice, it is unclear how these differences are likely to influence the obtained
summary estimates. This has highlighted the need for more standardised procedures for data
collection and reporting for individual studies. This is of particular importance during out-
breaks when research is delivered in a timely manner.
Whilst we intended to compare results from the meta-analyses with vaccination status and
intention to be vaccinated as outcomes, data were insufficient to draw meaningful compari-
sons. All the data for vaccine intention is found in the Appendix 23 p91 in S2 File. This is
important since the majority of data available for pertussis vaccination in pregnancy focused
on beliefs associated with vaccination intentions only [81, 88, 105, 106]. Whilst previous litera-
ture has shown intention to vaccinate can be a proxy for actual vaccination status, this may not
always be the case with maternal vaccination and additional research is needed [68, 107].
Our findings were largely consistent across countries; however, we recognize that the
majority of data come from high-income settings where national vaccine policies exist and,
therefore, the generalisability of these findings may be limited. We were unable to conduct a
sensitivity analysis to stratify results by Gross Domestic Product of each country as there were
too few studies included in each meta-analysis. Additionally, data from many studies relied
on self-reported vaccination status and did not verify medical records or vaccine registry data
which may have introduced a recall bias (reflected in the JBI quality assessment scoring). How-
ever, previous research in the field has indicated that this bias is unlikely to be substantial [108,
109]. A number of studies recruited participants using purposive or convenience sampling
(Table 1). Thus, we applied the Joanna Briggs Institute (JBI) Critical Appraisal Tools (JBI) to
assess potential biases among individual studies. Based on our results, we then performed a
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pre-defined sensitivity analysis (of high quality/low quality) presented in the Appendices
(Appendix 22, Appendix 24 p90, p92 in S2 File). We were unable to detect an influenced study
quality on our pooled analyses. A final limitation is that the exposures in our meta-analyses
were dichotomized, whereas in reality beliefs exist on a spectrum.
Vaccine refusal is undoubtedly multifactorial. However, our study has demonstrated that
factors specific to the vaccine, perhaps more so than the disease are highly influential. Inter-
ventions recommended to improve maternal vaccination uptake have ranged from text
reminders for prospective mothers to educational videos and motivational interviewing
techniques for HCPs [110–112]. Based on the results of this review, interventions designed
to impact maternal vaccine uptake should continue to encourage individualised HCP rec-
ommendations. Additionally, personalised counsel on the benefits and safety of a vaccine
should emphasize the vaccine’s protective effect on the pregnancy as well as discuss implica-
tions for foetal and childhood development. This is in contrast to traditional communica-
tion on disease threat in isolation. Readily accessible information that synthesizes the large
body of evidence that may otherwise appear contradictory to the general public, will facili-
tate healthcare consultations in addressing pregnancy and long-term concerns, such as
those identified in our review.
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